Similar articles

• Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.

  Greene BM, Taylor HR, Cupp EW, Murphy RP, White AT, Aziz MA, Schulz-Key H, D'Anna SA, Newland HS, Goldschmidt LP, et al. Greene BM, et al. N Engl J Med. 1985 Jul 18;313(3):133-8. doi: 10.1056/NEJM198507183130301. N Engl J Med. 1985. PMID: 3892293 Clinical Trial.
• [The therapeutic difficulties of ocular onchocerciasis].

  Toufic N. Toufic N. Arch Ophtalmol Rev Gen Ophtalmol. 1969 Nov;29(11):777-84. Arch Ophtalmol Rev Gen Ophtalmol. 1969. PMID: 4243964 French. No abstract available.
• Ocular onchocerciasis.

  Anderson J, Fuglsang H. Anderson J, et al. Trop Dis Bull. 1977 Apr;74(4):257-72. Trop Dis Bull. 1977. PMID: 329507 Review. No abstract available.
• [Senegalese experience with the efficacy of ivermectin (MK 933) in the treatment of human onchocerciasis (double-blind comparative study with diethylcarbamazine citrate) (DEC.C)].

  Diop Mar I, Diallo S, Diallo JS, Ndir O, Badiane S. Diop Mar I, et al. Bull Acad Natl Med. 1986 Jan;170(1):149-55. Bull Acad Natl Med. 1986. PMID: 3527347 Clinical Trial. French. No abstract available.
• Clinical pharmacokinetics of drugs against onchocerciasis.

  Orme M, Edwards G, Awadzi K, Breckenridge A. Orme M, et al. Acta Leiden. 1990;59(1-2):329-42. Acta Leiden. 1990. PMID: 2198757 Review. No abstract available.